Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Federal Trade Commission
Pharma
FTC to review Novo Holdings' Catalent buyout for 30 more days
After Novo Holdings pitched a $16.5 billion buyout of Catalent in February, the companies have given the FTC extra time to review the deal.
Fraiser Kansteiner
Apr 8, 2024 11:58am
FTC blasts Teva for 'improper' inhaler patents
Mar 25, 2024 10:04am
Lawmakers blast Biden administration's 'march-in' proposal
Feb 23, 2024 9:53am
FTC calls for 'expansive and flexible' use of march-in rights
Feb 6, 2024 5:00pm
IQVIA, DeepIntent abandon merger amid FTC scrutiny
Jan 5, 2024 10:54am
GSK, Amneal and Kaleo walk back patents after FTC's challenge
Dec 21, 2023 11:08am